zyvoxid 100 mg/5 ml zrnca za peroralno suspenzijo
pfizer luxembourg sarl - linezolid - zrnca za peroralno suspenzijo - linezolid 100 mg / 5 ml - linezolid
tygacil
pfizer europe ma eeig - tigecycline - bacterial infections; skin diseases, bacterial; soft tissue infections - antibacterials za sistemsko uporabo, - tygacil is indicated in adults and in children from the age of eight years for the treatment of the following infections: , complicated skin and soft tissue infections (cssti), excluding diabetic foot infections, complicated intra-abdominal infections (ciai) , tygacil should be used only in situations where other alternative antibiotics are not suitable. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti. ustrezno uporabo protibakterijsko agenti.
linezolid krka 2 mg/ml raztopina za infundiranje
krka, d.d., novo mesto - linezolid - raztopina za infundiranje - linezolid 2 mg / 1 ml - linezolid
linezolid krka 2 mg/ml raztopina za infundiranje
krka, d.d., novo mesto - linezolid - raztopina za infundiranje - linezolid 2 mg / 1 ml - linezolid
tigeciklin sandoz 50 mg prašek za raztopino za infundiranje
sandoz d.d. - tigeciklin - prašek za raztopino za infundiranje - tigeciklin 50 mg / 1 viala - tigeciklin
linezolid accord 2 mg/ml raztopina za infundiranje
accord healthcare - linezolid - raztopina za infundiranje - linezolid 2 mg / 1 ml - linezolid
tigecycline accord
accord healthcare s.l.u. - tigecycline - soft tissue infections; intraabdominal infections; bacterial infections; skin diseases, infectious - antibacterials za sistemsko uporabo, - tygecycline soglasju je navedeno v odrasle in otroke, starejše od osem let za zdravljenje naslednjih okužb (glej točki 4. 4 in 5. 1):zapleteno, kože in mehkih tkiv, okužbe (cssti), razen diabetično stopalo okužbe (glejte poglavje 4. 4)zapletena znotraj trebušne okužb (ciai)tygecycline soglasju naj se uporablja le v primerih, ko druge alternativne antibiotiki niso primerni (glej točki 4. 4, 4. 8 in 5. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.
upstaza
ptc therapeutics international limited - eladocagene exuparvovec - metabolizem aminokislin, vrojene napake - enzymes, other alimentary tract and metabolism products - upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic l amino acid decarboxylase (aadc) deficiency with a severe phenotype (see section 5.